Roman Butler Fullerton & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.96M | Buy |
11,481
+83
| +0.7% | +$19.3K | 0.71% | 33 |
|
|
2026
Q1 | $2.75M | Sell |
11,398
-267
| -2% | -$62.2K | 0.76% | 30 |
|
|
2025
Q4 | $2.55M | Buy |
11,665
+467
| +4% | +$92.3K | 0.67% | 38 |
|
|
2025
Q3 | $2.09M | Buy |
11,198
+19
| +0.2% | +$3.25K | 0.56% | 41 |
|
|
2025
Q2 | $1.88M | Sell |
11,179
-42
| -0.4% | -$6.46K | 0.55% | 41 |
|
|
2025
Q1 | $1.72M | Sell |
11,221
-185
| -2% | -$28.9K | 0.67% | 32 |
|
|
2024
Q4 | $1.74M | Sell |
11,406
-1,263
| -10% | -$196K | 0.55% | 43 |
|
|
2024
Q3 | $2.08M | Buy |
12,669
+44
| +0.3% | +$7.01K | 0.63% | 35 |
|
|
2024
Q2 | $1.89M | Sell |
12,625
-138
| -1% | -$20.5K | 0.61% | 40 |
|
|
2024
Q1 | $1.9M | Sell |
12,763
-67
| -0.5% | -$10.7K | 0.71% | 32 |
|
|
2023
Q4 | $2.05M | Sell |
12,830
-419
| -3% | -$64.2K | 0.8% | 30 |
|
|
2023
Q3 | $2.08M | Sell |
13,249
-621
| -4% | -$102K | 0.98% | 25 |
|
|
2023
Q2 | $2.2M | Sell |
13,870
-421
| -3% | -$67.9K | 1.01% | 23 |
|
|
2023
Q1 | $2.36M | Buy |
14,291
+1,696
| +13% | +$274K | 1.17% | 20 |
|
|
2022
Q4 | $2.17M | Buy |
12,595
+993
| +9% | +$171K | 1.12% | 20 |
|
|
2022
Q3 | $1.89M | Buy |
11,602
+251
| +2% | +$42.5K | 1.2% | 16 |
|
|
2022
Q2 | $2.02M | Buy |
11,351
+124
| +1% | +$22.1K | 1.12% | 19 |
|
|
2022
Q1 | $1.99M | Sell |
11,227
-587
| -5% | -$99.9K | 0.92% | 28 |
|
|
2021
Q4 | $2.02M | Buy |
11,814
+515
| +5% | +$84.3K | 0.89% | 30 |
|
|
2021
Q3 | $1.81M | Sell |
11,299
-470
| -4% | -$80.2K | 0.84% | 34 |
|
|
2021
Q2 | $1.94M | Sell |
11,769
-25
| -0.2% | -$4.14K | 0.94% | 27 |
|
|
2021
Q1 | $1.89M | Buy |
11,794
+67
| +0.6% | +$10.8K | 0.95% | 24 |
|
|
2020
Q4 | $1.85M | Buy |
11,727
+29
| +0.2% | +$4.28K | 1.09% | 22 |
|
|
2020
Q3 | $1.74M | Sell |
11,698
-44
| -0.4% | -$6.51K | 1.14% | 23 |
|
|
2020
Q2 | $1.65M | Buy |
11,742
+783
| +7% | +$114K | 1.18% | 19 |
|
|
2020
Q1 | $1.44M | Sell |
10,959
-379
| -3% | -$53.8K | 1.27% | 19 |
|
|
2019
Q4 | $1.65M | Sell |
11,338
-431
| -4% | -$58.5K | 1.09% | 21 |
|
|
2019
Q3 | $1.52M | Sell |
11,769
-993
| -8% | -$131K | 1.05% | 21 |
|
|
2019
Q2 | $1.78M | Buy |
12,762
+169
| +1% | +$23.4K | 1.19% | 16 |
|
|
2019
Q1 | $1.76M | Buy |
12,593
+187
| +2% | +$25K | 1.23% | 15 |
|
|
2018
Q4 | $1.61M | Buy |
+12,406
| New | +$1.73M | 1.37% | 13 |
|
Other funds holding JNJ
Roman Butler Fullerton & Co's JNJ Position: Q2 2026 in Review
Roman Butler Fullerton & Co increased its Johnson & Johnson (JNJ) stake by 0.73% in Q2 2026, buying an estimated $19.3K and bringing the position to 11,481 shares worth $2.96M. The position accounts for 0.71% of the portfolio, ranked #33.
Roman Butler Fullerton & Co first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Roman Butler Fullerton & Co held 11,481 shares of Johnson & Johnson worth $2.96M as of Q2 2026.
- Roman Butler Fullerton & Co bought 83 Johnson & Johnson shares in Q2 2026, an estimated $19.3K.
- Johnson & Johnson made up 0.71% of Roman Butler Fullerton & Co's portfolio in Q2 2026, its #33 holding.
- Roman Butler Fullerton & Co first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.